04:30 PM EST, 11/12/2024 (MT Newswires) -- Jack A. Khattar, Director, President, CEO, on November 08, 2024, sold 125,000 shares in Supernus Pharmaceuticals ( SUPN ) for $4,536,250. Following the Form 4 filing with the SEC, Khattar has control over a total of 1,948,622 shares of the company, with 926,172 shares held directly and 1,022,450 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000162828024047142/xslF345X05/wk-form4_1731445884.xml